ID   CERS2_HUMAN             Reviewed;         380 AA.
AC   Q96G23; D3DV06; Q5SZE5; Q9HD96; Q9NW79;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=Ceramide synthase 2;
DE            Short=CerS2;
DE   AltName: Full=LAG1 longevity assurance homolog 2;
DE   AltName: Full=SP260;
DE   AltName: Full=Tumor metastasis-suppressor gene 1 protein;
GN   Name=CERS2; Synonyms=LASS2, TMSG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INTERACTION WITH
RP   ATP6V0C; ASGR1; ASGR2 AND SLC22A1/OCT1.
RC   TISSUE=Liver;
RX   PubMed=11543633; DOI=10.1006/geno.2001.6614;
RA   Pan H., Qin W.-X., Huo K.-K., Wan D.-F., Yu Y., Xu Z.-G., Hu Q.-D.,
RA   Gu K.T., Zhou X.-M., Jiang H.-Q., Zhang P.-P., Huang Y., Li Y.-Y.,
RA   Gu J.-R.;
RT   "Cloning, mapping, and characterization of a human homologue of the
RT   yeast longevity assurance gene LAG1.";
RL   Genomics 77:58-64(2001).
RN   [2]
RP   SEQUENCE REVISION.
RA   Qin W.-X., Gu J.-R., Wan D.-F., Zhou X.-M., Jiang H.-Q., Zhang P.-P.,
RA   Huang Y., Qiu X.-K., Qian L.F., He L.P., Li H.N., Yu Y., Yu J.;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Xingfeng C., Yi G.;
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 59-380.
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 151-380.
RC   TISSUE=Prostatic carcinoma;
RA   Liu Y., Zheng J., Wu B., Fang W.;
RT   "Cancer metastasis-related gene.";
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341; THR-346; SER-348
RP   AND SER-349, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-19.
RC   TISSUE=Platelet;
RX   PubMed=16263699; DOI=10.1074/mcp.M500324-MCP200;
RA   Lewandrowski U., Moebius J., Walter U., Sickmann A.;
RT   "Elucidation of N-glycosylation sites on human platelet proteins: a
RT   glycoproteomic approach.";
RL   Mol. Cell. Proteomics 5:226-233(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341; THR-346; SER-348
RP   AND SER-349, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341; THR-346; SER-348
RP   AND SER-349, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-19.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   INTERACTION WITH ELOV1; HSD17B12 AND TECR.
RX   PubMed=20937905; DOI=10.1073/pnas.1005572107;
RA   Ohno Y., Suto S., Yamanaka M., Mizutani Y., Mitsutake S., Igarashi Y.,
RA   Sassa T., Kihara A.;
RT   "ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid
RT   synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:18439-18444(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341; THR-346; SER-348
RP   AND SER-349, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Suppresses the growth of cancer cells. May be involved
CC       in sphingolipid synthesis.
CC   -!- SUBUNIT: Interacts with ATP6V0C, ASGR1, ASGR2 and SLC22A1/OCT1.
CC       Interacts with ELOV1, HSD17B12 and TECR.
CC       {ECO:0000269|PubMed:11543633, ECO:0000269|PubMed:20937905}.
CC   -!- INTERACTION:
CC       P07306:ASGR1; NbExp=3; IntAct=EBI-1057080, EBI-1172335;
CC       P07307:ASGR2; NbExp=3; IntAct=EBI-1057080, EBI-1172636;
CC       P27449:ATP6V0C; NbExp=3; IntAct=EBI-1057080, EBI-721179;
CC       P07900:HSP90AA1; NbExp=2; IntAct=EBI-1057080, EBI-296047;
CC       O15245:SLC22A1; NbExp=3; IntAct=EBI-1057080, EBI-1172714;
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}; Multi-pass membrane protein {ECO:0000305}.
CC       Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in kidney, liver, brain, heart,
CC       placenta and lung. {ECO:0000269|PubMed:11543633}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91505.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF177338; AAG17982.2; -; mRNA.
DR   EMBL; AY091458; AAM12028.1; -; mRNA.
DR   EMBL; AL590133; CAI13330.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53497.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53498.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53499.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53502.1; -; Genomic_DNA.
DR   EMBL; BC001357; AAH01357.2; -; mRNA.
DR   EMBL; BC010032; AAH10032.1; -; mRNA.
DR   EMBL; AK001105; BAA91505.1; ALT_INIT; mRNA.
DR   EMBL; AF189062; AAF01058.4; -; mRNA.
DR   CCDS; CCDS973.1; -.
DR   RefSeq; NP_071358.1; NM_022075.4.
DR   RefSeq; NP_859530.1; NM_181746.3.
DR   RefSeq; XP_011507754.1; XM_011509452.2.
DR   UniGene; Hs.744017; -.
DR   ProteinModelPortal; Q96G23; -.
DR   SMR; Q96G23; -.
DR   BioGrid; 118992; 40.
DR   IntAct; Q96G23; 24.
DR   STRING; 9606.ENSP00000271688; -.
DR   SwissLipids; SLP:000000256; -.
DR   iPTMnet; Q96G23; -.
DR   PhosphoSitePlus; Q96G23; -.
DR   SwissPalm; Q96G23; -.
DR   BioMuta; CERS2; -.
DR   DMDM; 51316514; -.
DR   EPD; Q96G23; -.
DR   MaxQB; Q96G23; -.
DR   PaxDb; Q96G23; -.
DR   PeptideAtlas; Q96G23; -.
DR   PRIDE; Q96G23; -.
DR   DNASU; 29956; -.
DR   Ensembl; ENST00000271688; ENSP00000271688; ENSG00000143418.
DR   Ensembl; ENST00000368954; ENSP00000357950; ENSG00000143418.
DR   GeneID; 29956; -.
DR   KEGG; hsa:29956; -.
DR   UCSC; uc001evy.3; human.
DR   CTD; 29956; -.
DR   DisGeNET; 29956; -.
DR   GeneCards; CERS2; -.
DR   HGNC; HGNC:14076; CERS2.
DR   HPA; HPA027262; -.
DR   MIM; 606920; gene.
DR   neXtProt; NX_Q96G23; -.
DR   OpenTargets; ENSG00000143418; -.
DR   PharmGKB; PA30300; -.
DR   eggNOG; KOG1607; Eukaryota.
DR   eggNOG; COG5058; LUCA.
DR   GeneTree; ENSGT00550000074401; -.
DR   HOVERGEN; HBG052310; -.
DR   InParanoid; Q96G23; -.
DR   KO; K04710; -.
DR   OMA; GKQPKQA; -.
DR   OrthoDB; EOG091G0BWM; -.
DR   PhylomeDB; Q96G23; -.
DR   TreeFam; TF314319; -.
DR   BRENDA; 2.3.1.24; 2681.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   ChiTaRS; CERS2; human.
DR   GeneWiki; LASS2; -.
DR   GenomeRNAi; 29956; -.
DR   PRO; PR:Q96G23; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143418; -.
DR   CleanEx; HS_LASS2; -.
DR   ExpressionAtlas; Q96G23; baseline and differential.
DR   Genevisible; Q96G23; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0050291; F:sphingosine N-acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IBA:GO_Central.
DR   GO; GO:0048681; P:negative regulation of axon regeneration; ISS:BHF-UCL.
DR   GO; GO:1900148; P:negative regulation of Schwann cell migration; ISS:BHF-UCL.
DR   GO; GO:1905045; P:negative regulation of Schwann cell proliferation involved in axon regeneration; ISS:BHF-UCL.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR016439; Lag1/Lac1.
DR   InterPro; IPR006634; TLC-dom.
DR   PANTHER; PTHR12560; PTHR12560; 1.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF03798; TRAM_LAG1_CLN8; 1.
DR   PIRSF; PIRSF005225; LAG1_LAC1; 1.
DR   SMART; SM00724; TLC; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50922; TLC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Endoplasmic reticulum; Glycoprotein;
KW   Homeobox; Lipid biosynthesis; Lipid metabolism; Membrane; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    380       Ceramide synthase 2.
FT                                /FTId=PRO_0000185509.
FT   TOPO_DOM      1     40       Lumenal. {ECO:0000255}.
FT   TRANSMEM     41     61       Helical. {ECO:0000255}.
FT   TOPO_DOM     62    139       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    140    160       Helical. {ECO:0000255}.
FT   TOPO_DOM    161    180       Lumenal. {ECO:0000255}.
FT   TRANSMEM    181    201       Helical. {ECO:0000255}.
FT   TOPO_DOM    202    208       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    209    229       Helical. {ECO:0000255}.
FT   TOPO_DOM    230    263       Lumenal. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TOPO_DOM    285    303       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    304    324       Helical. {ECO:0000255}.
FT   TOPO_DOM    325    380       Lumenal. {ECO:0000255}.
FT   DOMAIN      131    332       TLC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00205}.
FT   DNA_BIND     67    128       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOD_RES     341    341       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     346    346       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     348    348       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   CARBOHYD     19     19       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16263699,
FT                                ECO:0000269|PubMed:19159218}.
FT   VARIANT     115    115       E -> A (in dbSNP:rs267738).
FT                                /FTId=VAR_052325.
FT   CONFLICT    154    154       I -> T (in Ref. 8; AAF01058).
FT                                {ECO:0000305}.
FT   CONFLICT    345    345       E -> V (in Ref. 8; AAF01058).
FT                                {ECO:0000305}.
FT   CONFLICT    353    353       E -> K (in Ref. 8; AAF01058).
FT                                {ECO:0000305}.
SQ   SEQUENCE   380 AA;  44876 MW;  C8CEAF6AAD0B4577 CRC64;
     MLQTLYDYFW WERLWLPVNL TWADLEDRDG RVYAKASDLY ITLPLALLFL IVRYFFELYV
     ATPLAALLNI KEKTRLRAPP NATLEHFYLT SGKQPKQVEV ELLSRQSGLS GRQVERWFRR
     RRNQDRPSLL KKFREASWRF TFYLIAFIAG MAVIVDKPWF YDMKKVWEGY PIQSTIPSQY
     WYYMIELSFY WSLLFSIASD VKRKDFKEQI IHHVATIILI SFSWFANYIR AGTLIMALHD
     SSDYLLESAK MFNYAGWKNT CNNIFIVFAI VFIITRLVIL PFWILHCTLV YPLELYPAFF
     GYYFFNSMMG VLQLLHIFWA YLILRMAHKF ITGKLVEDER SDREETESSE GEEAAAGGGA
     KSRPLANGHP ILNNNHRKND
//
